All In Biotech

Drug Trial Radar · NCT01148576

Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients

Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients-A Randomized, Double-Blinded, Controlled Trial

Last checked: Nov 20, 2026Latest source record: Jun 22, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 1,200 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

1,200

Planned (sponsor's estimate)

Start

Jun 2010

Primary completion

Dec 2011

Study completion Feb 2012

Sponsor

Lead sponsor
Zhejiang UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 22, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To investigate the influence of hepatic steatosis on the anti-viral effect of entecavir in chronic hepatitis B patients.

Conditions

  • Chronic Hepatitis B
  • Hepatic Steatosis

Interventions

  • entecavirDrug

    entecavir 0.5 mg qd for 12 months

  • entecavirDrug

    entecavir 0.5 mg qd for 12 months

  • essentiale + entecavirDrug

    entecavir 0.5 mg qd for 12 months,Essentiale 2 tablets tid in the first 3 months and 1 tablets tid in the rest 9 months

  • Vitamin E + entecavirDrug

    entecavir 0.5 mg qd for 12 months, Vitamin E: 100 mg bid for 12 months

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Differences in the anti-viral effect of entecavir among CHB patients and CHB + hepatic steatosis patients who received different drugsTime frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The first affiliated hospital, college of medicine, zhejiang university

    Hangzhou, Zhejaing, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.